Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Tumor-Lysis Syndrome in Relapsed or Refractory Multiple Myeloma Patients Treated with Proteasome Inhibitors

Kazuhito Suzuki, MD, Kaichi Nishiwaki, MD, Tadahiro Gunji, MD, Mitsuji Katori, MD, Rika Hosoba, MD, Kei Hirano, MD, Hidekazu Masuoka, Shingo Yano, MD PhD

Blood (2018) 132 (Supplement 1): 5631.

https://doi.org/10.1182/blood-2018-99-114822

Published: 2018

Journal Articles

R-CHOP Therapy Cannot Overcome CD5 Positive Non-GCB Subtype of DLBCL

Yuko Mishima, MD PhD, Masahiro Yokoyama, MD, Noriko Nishimura, MD PhD, Kyoko Ueda, MD, Tadahiro Gunji, MD, Hideaki Nitta, MD PhD, Yoshiharu Kusano, MD, Norihito Inoue, MD, Anna Takahashi, MD, Naoko Tsuyama, MD, Kengo Takeuchi, MDPhD, Yasuhito Terui, MD PhD, Kiyohiko Hatake, MD PhD

Blood (2015) 126 (23): 1507.

https://doi.org/10.1182/blood.V126.23.1507.1507

Published: 2015

Journal Articles

The Presence of M Protein Is Strongly Associated with Very Poor Prognosis in Patients with Extranodal Diffuse Large B-Cell Lymphoma

Hideaki Nitta, MD PhD, Yasuhito Terui, MD PhD, Masahiro Yokoyama, MD, Yuko Mishima, MD PhD, Noriko Nishimura, MD PhD, Kyoko Ueda, MD, Tadahiro Gunji, MD, Yoshiharu Kusano, MD, Norihito Inoue, MD, Anna Takahashi, MD, Naoko Tsuyama, MD, Kengo Takeuchi, MD PhD, Kiyohiko Hatake, MD PhD

Blood (2015) 126 (23): 5638.

https://doi.org/10.1182/blood.V126.23.5638.5638

Published: 2015

Journal Articles

Elevated CRP Is Associated with Longer Survival of PTCL-NOS in Peripheral T-Cell Lymphomas: A Single Institution Research

Tadahiro Gunji, MD, Yasuhito Terui, MD PhD, Anna Takahashi, MD, Norihito Inoue, MD, Yoshiharu Kusano, MD, Hideaki Nitta, MD PhD, Kyoko Ueda, MD, Noriko Nishimura, MD PhD, Yuko Mishima, MD PhD, Masahiro Yokoyama, MD, Kiyohiko Hatake, MD PhD

Blood (2015) 126 (23): 5067.

https://doi.org/10.1182/blood.V126.23.5067.5067

Published: 2015

Journal Articles

Rituximab Maintenance Therapy Is an Effective Therapy in over-Sixties with Mantle Cell Lymphoma

Norihito Inoue, MD, Noriko Nishimura, MD PhD, Anna Takahashi, MD, Yoshiharu Kusano, MD, Tadahiro Gunji, MD, Hideaki Nitta, MD PhD, Kyoko Ueda, MD, Yuko Mishima, MD PhD, Masahiro Yokoyama, MD, Yasuhito Terui, MD PhD, Kiyohiko Hatake, MD PhD

Blood (2015) 126 (23): 5081.

https://doi.org/10.1182/blood.V126.23.5081.5081

Published: 2015

Journal Articles

80% Dose R-CHOP Is Suitable Chemotherapy for Very Elderly Patients with DLBCL

Anna Takahashi, MD, Yuko Mishima, MD PhD, Norihito Inoue, MD, Yoshiharu Kusano, MD, Tadahiro Gunji, MD, Kyoko Ueda, MD, Noriko Nishimura, MD PhD, Hideaki Nitta, MD PhD, Masahiro Yokoyama, MD, Naoko Tsuyama, MD, Kengo Takeuchi, MD PhD, Yasuhito Terui, MD PhD, Kiyohiko Hatake, MD PhD

Blood (2015) 126 (23): 5094.

https://doi.org/10.1182/blood.V126.23.5094.5094

Published: 2015

Journal Articles

Higher Titer of Epstein-Barr Virus Nuclear Antigen Might be a Marker of Poorer Prognosis in Patients with Peripheral T-Cell Lymphoma, Not Otherwise Specified

Yoshiharu Kusano, MD, Yasuhito Terui, MD PhD, Kyoko Ueda, MD, Masahiro Yokoyama, MD, Noriko Nishimura, MD PhD, Yuko Mishima, MD PhD, Tadahiro Gunji, MD, Hideaki Nitta, MD PhD, Anna Takahasi, MD, Norihito Inoue, MD, Kiyohiko Hatake, MD PhD

Blood (2015) 126 (23): 5013.

https://doi.org/10.1182/blood.V126.23.5013.5013

Published: 2015

Journal Articles

Higher Titer of Anti-EBV Nuclear Antigen Antibodies Might be a Marker of Poorer Prognosis in Patients with Peripheral T-Cell Lymphoma, Not Otherwise Specified

Yoshiharu Kusano, MD, Yasuhito Terui, MD PhD, Kyoko Ueda, MD, Yuko Mishima, MD PhD, Noriko Nishimura, MD PhD, Masahiro Yokoyama, MD, Hideaki Nitta, MD PhD, Tadahiro Gunji, MD, Norihito Inoue, MD, Anna Takahasi, MD, Kengo Takeuchi, MD PhD, Kiyohiko Hatake, MD PhD

Blood (2015) 126 (23): 5016.

https://doi.org/10.1182/blood.V126.23.5016.5016

Published: 2015

Journal Articles

Serum Levels of CCL22 and CCL25 Might Predict Skin Rash Induction、the Common Adverse Event By Bendamustine Therapy in Malignant Lymphoma

Yasuhito Terui, MD PhD, Kyoko Ueda, MD, Yoshiharu Kusano, MD, Tadahiro Gunji, MD, Noriko Nishimura, MD PhD, Kiyohiko Hatake, MD PhD

Blood (2014) 124 (21): 5427.

https://doi.org/10.1182/blood.V124.21.5427.5427

Published: 2014

NARROW

Tumor-Lysis Syndrome in Relapsed or Refractory Multiple Myeloma Patients Treated with Proteasome Inhibitors

R-CHOP Therapy Cannot Overcome CD5 Positive Non-GCB Subtype of DLBCL

The Presence of M Protein Is Strongly Associated with Very Poor Prognosis in Patients with Extranodal Diffuse Large B-Cell Lymphoma

Elevated CRP Is Associated with Longer Survival of PTCL-NOS in Peripheral T-Cell Lymphomas: A Single Institution Research

Rituximab Maintenance Therapy Is an Effective Therapy in over-Sixties with Mantle Cell Lymphoma

80% Dose R-CHOP Is Suitable Chemotherapy for Very Elderly Patients with DLBCL

Higher Titer of Epstein-Barr Virus Nuclear Antigen Might be a Marker of Poorer Prognosis in Patients with Peripheral T-Cell Lymphoma, Not Otherwise Specified

Higher Titer of Anti-EBV Nuclear Antigen Antibodies Might be a Marker of Poorer Prognosis in Patients with Peripheral T-Cell Lymphoma, Not Otherwise Specified

Serum Levels of CCL22 and CCL25 Might Predict Skin Rash Induction、the Common Adverse Event By Bendamustine Therapy in Malignant Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only